Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease

Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of medicine 2024-03, Vol.137 (3), p.202-209
Hauptverfasser: Krittanawong, Chayakrit, Escobar, Johao, Virk, Hafeez Ul Hassan, Alam, Mahboob, Virani, Salim, Lavie, Carl J., Narayan, K M Venkat, Sharma, Raman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 209
container_issue 3
container_start_page 202
container_title The American journal of medicine
container_volume 137
creator Krittanawong, Chayakrit
Escobar, Johao
Virk, Hafeez Ul Hassan
Alam, Mahboob
Virani, Salim
Lavie, Carl J.
Narayan, K M Venkat
Sharma, Raman
description Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.
doi_str_mv 10.1016/j.amjmed.2023.10.028
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2892012511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000293432300709X</els_id><sourcerecordid>2892012511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-d7df2535110afe0aaed53f35b311582de19d4f5eab7beab2f7991f9997e72dc3</originalsourceid><addsrcrecordid>eNp9kEtLAzEQx4Motla_gUiOXrbm0XQ3F6HU-oCKgr2HNJnQlN3ummzV_fZmab16mWFm_vP6IXRNyZgSOr3bjnW1rcCOGWE8pcaEFSdoSIUQWU6n7BQNCSEsk3zCB-gixm0KiRTTczTguSyIzMkQfSy9g9h2JeBZ04Ramw3WO4tfwXqjS7zaQNBNh2uHl_U3BLz4aQNUvu3wOwTf9OUSz0ILocMPPoKOcInOnC4jXB39CK0eF6v5c7Z8e3qZz5aZmZCizWxuHRNcUEq0A6I1WMEdF2tOqSiYBSrtxAnQ63ydDHO5lNRJKXPImTV8hG4PY9PZn_v0hKp8NFCWegf1PipWSEYoS_OTdHKQmlDHGMCpJvhKh05RonqaaqsONFVPs88mmqnt5rhhv-5rf01_-JLg_iCA9OaXh6Ci8bAzCV4A0ypb-_83_AK14ohb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2892012511</pqid></control><display><type>article</type><title>Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Krittanawong, Chayakrit ; Escobar, Johao ; Virk, Hafeez Ul Hassan ; Alam, Mahboob ; Virani, Salim ; Lavie, Carl J. ; Narayan, K M Venkat ; Sharma, Raman</creator><creatorcontrib>Krittanawong, Chayakrit ; Escobar, Johao ; Virk, Hafeez Ul Hassan ; Alam, Mahboob ; Virani, Salim ; Lavie, Carl J. ; Narayan, K M Venkat ; Sharma, Raman</creatorcontrib><description>Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.</description><identifier>ISSN: 0002-9343</identifier><identifier>ISSN: 1555-7162</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/j.amjmed.2023.10.028</identifier><identifier>PMID: 37980970</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Clopidogrel ; Diabetes Mellitus ; Humans ; Hypertension - complications ; Life Style ; Lifestyle approach ; Lifestyle medicine ; Lower Extremity ; PAD ; Peripheral Arterial Disease - complications ; Peripheral artery disease ; Platelet Aggregation Inhibitors - therapeutic use ; Risk Factors</subject><ispartof>The American journal of medicine, 2024-03, Vol.137 (3), p.202-209</ispartof><rights>2023 Elsevier Inc.</rights><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-d7df2535110afe0aaed53f35b311582de19d4f5eab7beab2f7991f9997e72dc3</citedby><cites>FETCH-LOGICAL-c408t-d7df2535110afe0aaed53f35b311582de19d4f5eab7beab2f7991f9997e72dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S000293432300709X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37980970$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krittanawong, Chayakrit</creatorcontrib><creatorcontrib>Escobar, Johao</creatorcontrib><creatorcontrib>Virk, Hafeez Ul Hassan</creatorcontrib><creatorcontrib>Alam, Mahboob</creatorcontrib><creatorcontrib>Virani, Salim</creatorcontrib><creatorcontrib>Lavie, Carl J.</creatorcontrib><creatorcontrib>Narayan, K M Venkat</creatorcontrib><creatorcontrib>Sharma, Raman</creatorcontrib><title>Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.</description><subject>Aged</subject><subject>Clopidogrel</subject><subject>Diabetes Mellitus</subject><subject>Humans</subject><subject>Hypertension - complications</subject><subject>Life Style</subject><subject>Lifestyle approach</subject><subject>Lifestyle medicine</subject><subject>Lower Extremity</subject><subject>PAD</subject><subject>Peripheral Arterial Disease - complications</subject><subject>Peripheral artery disease</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Risk Factors</subject><issn>0002-9343</issn><issn>1555-7162</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEQx4Motla_gUiOXrbm0XQ3F6HU-oCKgr2HNJnQlN3ummzV_fZmab16mWFm_vP6IXRNyZgSOr3bjnW1rcCOGWE8pcaEFSdoSIUQWU6n7BQNCSEsk3zCB-gixm0KiRTTczTguSyIzMkQfSy9g9h2JeBZ04Ramw3WO4tfwXqjS7zaQNBNh2uHl_U3BLz4aQNUvu3wOwTf9OUSz0ILocMPPoKOcInOnC4jXB39CK0eF6v5c7Z8e3qZz5aZmZCizWxuHRNcUEq0A6I1WMEdF2tOqSiYBSrtxAnQ63ydDHO5lNRJKXPImTV8hG4PY9PZn_v0hKp8NFCWegf1PipWSEYoS_OTdHKQmlDHGMCpJvhKh05RonqaaqsONFVPs88mmqnt5rhhv-5rf01_-JLg_iCA9OaXh6Ci8bAzCV4A0ypb-_83_AK14ohb</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Krittanawong, Chayakrit</creator><creator>Escobar, Johao</creator><creator>Virk, Hafeez Ul Hassan</creator><creator>Alam, Mahboob</creator><creator>Virani, Salim</creator><creator>Lavie, Carl J.</creator><creator>Narayan, K M Venkat</creator><creator>Sharma, Raman</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202403</creationdate><title>Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease</title><author>Krittanawong, Chayakrit ; Escobar, Johao ; Virk, Hafeez Ul Hassan ; Alam, Mahboob ; Virani, Salim ; Lavie, Carl J. ; Narayan, K M Venkat ; Sharma, Raman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-d7df2535110afe0aaed53f35b311582de19d4f5eab7beab2f7991f9997e72dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Clopidogrel</topic><topic>Diabetes Mellitus</topic><topic>Humans</topic><topic>Hypertension - complications</topic><topic>Life Style</topic><topic>Lifestyle approach</topic><topic>Lifestyle medicine</topic><topic>Lower Extremity</topic><topic>PAD</topic><topic>Peripheral Arterial Disease - complications</topic><topic>Peripheral artery disease</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krittanawong, Chayakrit</creatorcontrib><creatorcontrib>Escobar, Johao</creatorcontrib><creatorcontrib>Virk, Hafeez Ul Hassan</creatorcontrib><creatorcontrib>Alam, Mahboob</creatorcontrib><creatorcontrib>Virani, Salim</creatorcontrib><creatorcontrib>Lavie, Carl J.</creatorcontrib><creatorcontrib>Narayan, K M Venkat</creatorcontrib><creatorcontrib>Sharma, Raman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krittanawong, Chayakrit</au><au>Escobar, Johao</au><au>Virk, Hafeez Ul Hassan</au><au>Alam, Mahboob</au><au>Virani, Salim</au><au>Lavie, Carl J.</au><au>Narayan, K M Venkat</au><au>Sharma, Raman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>2024-03</date><risdate>2024</risdate><volume>137</volume><issue>3</issue><spage>202</spage><epage>209</epage><pages>202-209</pages><issn>0002-9343</issn><issn>1555-7162</issn><eissn>1555-7162</eissn><abstract>Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37980970</pmid><doi>10.1016/j.amjmed.2023.10.028</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9343
ispartof The American journal of medicine, 2024-03, Vol.137 (3), p.202-209
issn 0002-9343
1555-7162
1555-7162
language eng
recordid cdi_proquest_miscellaneous_2892012511
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aged
Clopidogrel
Diabetes Mellitus
Humans
Hypertension - complications
Life Style
Lifestyle approach
Lifestyle medicine
Lower Extremity
PAD
Peripheral Arterial Disease - complications
Peripheral artery disease
Platelet Aggregation Inhibitors - therapeutic use
Risk Factors
title Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T02%3A08%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lifestyle%20Approach%20and%20Medical%20Therapy%20of%20Lower%20Extremity%20Peripheral%20Artery%20Disease&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Krittanawong,%20Chayakrit&rft.date=2024-03&rft.volume=137&rft.issue=3&rft.spage=202&rft.epage=209&rft.pages=202-209&rft.issn=0002-9343&rft.eissn=1555-7162&rft_id=info:doi/10.1016/j.amjmed.2023.10.028&rft_dat=%3Cproquest_cross%3E2892012511%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2892012511&rft_id=info:pmid/37980970&rft_els_id=S000293432300709X&rfr_iscdi=true